V Hird
-
- Monoclonal and Polyclonal Antibodies Research 12
- Radiopharmaceutical Chemistry and Applications 7
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 6
- Oncology top 10%
- HER2/EGFR in Cancer Research 2
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 2
-
- Neuroendocrine Tumor Research Advances 5
-
- Lymphoma Diagnosis and Treatment 3
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- M.H.F. SullivanJohn S. StewartH LambertAgamemnon A. EpenetosD SnookGregory SivolapenkoA. A. EpenetosP. R. Mason
- Journals
- British Journal of Cancer (2 papers)BJOG An International Journal of Obstetrics & Gynaecology (2 papers)Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesGreece
In The Last Decade
V Hird
19 papers receiving 947 citations
Peers
Comparison fields: 5 of 79
- Radiology, Nuclear Medicine and Imaging 618
- Reproductive Medicine 203
- Oncology 249
- Immunology 179
- Obstetrics and Gynecology 65
Countries citing papers authored by V Hird
This map shows the geographic impact of V Hird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V Hird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V Hird more than expected).
Fields of papers citing papers by V Hird
This network shows the impact of papers produced by V Hird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V Hird. The network helps show where V Hird may publish in the future.
Co-authorship network
The 25 scholars most cited alongside V Hird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 17 | |
| 2 | 2011 | 38 | |
| 3 | 2009 | 57 | |
| 4 | 2000 | 69 | |
| 5 | 1998 | 62 | |
| 6 | 1994 | 9 | |
| 7 | 1994 | 38 | |
| 8 | 1993 | 132 | |
| 9 | 1991 | 33 | |
| 10 | 1990 | 102 | |
| 11 | 1990 | 75 | |
| 12 | 1990 | 4 | |
| 13 | 1990 | 88 | |
| 14 | Clearance of 131I-labeled murine monoclonal antibody from patients' blood by intravenous human anti-murine immunoglobulin antibody. | 1990 | 16 |
| 15 | 1989 | 88 | |
| 16 | 1989 | 39 | |
| 17 | 1989 | 13 | |
| 18 | 1988 | 46 | |
| 19 | Intraperitoneal 131I- and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry. | 1988 | 53 |
About V Hird
V Hird is a scholar working on Reproductive Medicine, Radiology, Nuclear Medicine and Imaging and Obstetrics and Gynecology, having authored 19 papers that have together received 979 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Ovarian cancer diagnosis and treatment (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), HER2/EGFR in Cancer Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (618 citations), Reproductive Medicine (203 citations) and Oncology (249 citations). V Hird has collaborated with scholars based in United Kingdom, United States and Greece. Frequent co-authors include M.H.F. Sullivan, John S. Stewart, H Lambert, Agamemnon A. Epenetos, D Snook, Gregory Sivolapenko, A. A. Epenetos, P. R. Mason, Anthony Maraveyas and D Snook. Their work appears in journals such as British Journal of Cancer, BJOG An International Journal of Obstetrics & Gynaecology, Cancer, International Journal of Radiation Oncology*Biology*Physics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.